TABLE 6B - NEW PROCEDURE CODES
Procedure Code	Description	O.R.	MDC	MS-DRG
02LW0DJ^	Occlusion of Thoracic Aorta, Descending with Intraluminal Device, Temporary, Open Approach	Y	05	270, 271, 272
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""				981, 982, 983
04L00DJ^	Occlusion of Abdominal Aorta with Intraluminal Device, Temporary, Open Approach	Y	05	268, 269
""			06	356, 357, 358
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
0P530Z3^	Destruction of Cervical Vertebra using Laser Interstitial Thermal Therapy, Open Approach	Y	03	143, 144, 145
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0P533Z3^	Destruction of Cervical Vertebra using Laser Interstitial Thermal Therapy, Percutaneous Approach	Y	03	143, 144, 145
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0P534Z3^	Destruction of Cervical Vertebra using Laser Interstitial Thermal Therapy, Percutaneous Endoscopic Approach	Y	03	143, 144, 145
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0P540Z3^	Destruction of Thoracic Vertebra using Laser Interstitial Thermal Therapy, Open Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0P543Z3^	Destruction of Thoracic Vertebra using Laser Interstitial Thermal Therapy, Percutaneous Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0P544Z3^	Destruction of Thoracic Vertebra using Laser Interstitial Thermal Therapy, Percutaneous Endoscopic Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0Q500Z3^	Destruction of Lumbar Vertebra using Laser Interstitial Thermal Therapy, Open Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0Q503Z3^	Destruction of Lumbar Vertebra using Laser Interstitial Thermal Therapy, Percutaneous Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0Q504Z3^	Destruction of Lumbar Vertebra using Laser Interstitial Thermal Therapy, Percutaneous Endoscopic Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0Q510Z3^	Destruction of Sacrum using Laser Interstitial Thermal Therapy, Open Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0Q513Z3^	Destruction of Sacrum using Laser Interstitial Thermal Therapy, Percutaneous Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
0Q514Z3^	Destruction of Sacrum using Laser Interstitial Thermal Therapy, Percutaneous Endoscopic Approach	Y	08	495, 496, 497
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				987, 988, 989
302A3H0^	Transfusion of Autologous Whole Blood into Bone Marrow, Percutaneous Approach	N		
302A3H1^	Transfusion of Nonautologous Whole Blood into Bone Marrow, Percutaneous Approach	N		
302A3J0^	Transfusion of Autologous Serum Albumin into Bone Marrow, Percutaneous Approach	N		
302A3J1^	Transfusion of Nonautologous Serum Albumin into Bone Marrow, Percutaneous Approach	N		
302A3K0^	Transfusion of Autologous Frozen Plasma into Bone Marrow, Percutaneous Approach	N		
302A3K1^	Transfusion of Nonautologous Frozen Plasma into Bone Marrow, Percutaneous Approach	N		
302A3L0^	Transfusion of Autologous Fresh Plasma into Bone Marrow, Percutaneous Approach	N		
302A3L1^	Transfusion of Nonautologous Fresh Plasma into Bone Marrow, Percutaneous Approach	N		
302A3N0^	Transfusion of Autologous Red Blood Cells into Bone Marrow, Percutaneous Approach	N		
302A3N1^	Transfusion of Nonautologous Red Blood Cells into Bone Marrow, Percutaneous Approach	N		
302A3P0^	Transfusion of Autologous Frozen Red Cells into Bone Marrow, Percutaneous Approach	N		
302A3P1^	Transfusion of Nonautologous Frozen Red Cells into Bone Marrow, Percutaneous Approach	N		
302A3R0^	Transfusion of Autologous Platelets into Bone Marrow, Percutaneous Approach	N		
302A3R1^	Transfusion of Nonautologous Platelets into Bone Marrow, Percutaneous Approach	N		
5A09B5K	Assistance with Respiratory Ventilation, Less than 8 Consecutive Hours, Intubated Prone Positioning	N		
5A09C5K	Assistance with Respiratory Ventilation, 8-24 Consecutive Hours, Intubated Prone Positioning	N		
5A09D5K	Assistance with Respiratory Ventilation, Greater than 24 Consecutive Hours, Intubated Prone Positioning	N		
X2H03R9	Insertion of Intraluminal Device, Bioprosthetic Valve into Inferior Vena Cava, Percutaneous Approach, New Technology Group 9	N		
X2H13R9	Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9	Y	01	040, 041, 042
""			04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			10	628, 629, 630
""			11	673, 674, 675
""			12	715, 716, 717, 718
""			13	749, 750
""			14	769, 817, 818, 819
""			16	802, 803, 804
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X2UQ0P9	Supplement Right Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""				981, 982, 983
X2UR0P9	Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""				981, 982, 983
XNR80D9	Replacement of Skull with Ultrasound Penetrable Synthetic Substitute, Open Approach, New Technology Group 9	Y	01	023, 024, 025, 026, 027
""			03	143, 144, 145
""			08	515, 516, 517
""			09	579, 580, 581
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	955
""				981, 982, 983
XW013G6^	Introduction of REGN-COV2 Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6	N		
XW0DXK8^	Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8	N		
XW0G7K8^	Introduction of Sabizabulin into Upper GI, Via Natural or Artificial Opening, New Technology Group 8	N		
XW0H7K8^	Introduction of Sabizabulin into Lower GI, Via Natural or Artificial Opening, New Technology Group 8	N		
XW133H9	Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9	N**	PRE	016, 017
XW133J8^	Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8	N**	PRE	016, 017
XW143H9	Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9	N**	PRE	016, 017
XW143J8^	Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8	N**	PRE	016, 017

	Notes:
	(^)-These codes were implemented on April 1, 2023.
	(**)-Non-OR procedure affects DRGs
